Results 171 to 180 of about 1,881,376 (382)

High Prevalence of Neutralizing Antibodies After Long-term Botulinum Neurotoxin Therapy [PDF]

, 2021
Steven Galetta, Aravind Ganesh, Ariane Lewis, James Siegler, P Albrecht, A Jansen, J Lee   +6 more
openalex   +1 more source

Prevalence of antibodies to four different rotavirus strains in different age groups of cattle [PDF]

, 1990
Neutralizing antibody titers to four bovine rotavirus strains, representing three serotypes, were measured in 160 sera from cattle of different age groups.
Büssow, Harald, Eichhorn, Werner, Sidoti, Josette, Sotek, Jan   +3 more
core  

Amine‐Functionalized Chitosan/dECM Composite Promotes Cutaneous Regeneration and Hair Follicle Activation by Regulating Oxidative Stress and Inflammation

Advanced Healthcare Materials, EarlyView.
An amine‐functionalized chitosan and hydrolyzed dECM composite promotes cutaneous regeneration by modulating oxidative stress and inflammatory pathways. The material accelerates wound closure and stimulates hair follicle activation in UV‐damaged cutaneous tissue.
Yu‐Jin Kim, Seokheon Hong, Jae Hwi Lee, Jongmin Lee, Jae Jun Kang, Jiseon Bae, Jino Kim, Dong‐Hwee Kim, Jin Yoo, Mi Sun Cha, Su Hee Kim, Youngmee Jung   +11 more
wiley   +1 more source

Cryo-EM structures of HCV E2 glycoprotein bound to neutralizing and non-neutralizing antibodies determined using bivalent Fabs as fiducial markers

Communications Biology
Global elimination of hepatitis C virus (HCV) will require an effective cross-genotype vaccine. The HCV E2 envelope glycoprotein is the main target of neutralizing antibodies but also contains epitopes that elicit non-neutralizing antibodies which may ...
Salman Shahid, Sharanbasappa S. Karade, S. Saif Hasan, Rui Yin, Liqun Jiang, Yanxin Liu, Nathaniel Felbinger, Liudmila Kulakova, Eric A. Toth, Zhen-Yong Keck, Steven K. H. Foung, Thomas R. Fuerst, Brian G. Pierce, Roy A. Mariuzza   +13 more
doaj   +1 more source

Evaluation of the Dual Impact of Nanotechnologies on Health and Environment Through Alternative Bridging Models

Advanced Healthcare Materials, EarlyView.
This review explores how alternative invertebrate and small‐vertebrate models advance the evaluation of nanomaterials across medicine and environmental science. By bridging cellular and organismal levels, these models enable integrated assessment of toxicity, biodistribution, and therapeutic performance.
Marie Celine Lefevre, Margherita Bernardeschi, Matteo Battaglini, Gianni Ciofani   +3 more
wiley   +1 more source

Visualization of immune pathways that enhance the neutralizing antibody response to vaccines after primary immunization

mBio
We examined the relationship between the association of a vaccine antigen with immune cells in secondary lymphoid organs shortly after immunization and the resulting neutralizing antibody response induced by that antigen using three antigenic forms of ...
Anita Verma, Roberto De Pascalis, Christopher P. Mocca, Xiaohong Li, Drusilla L. Burns   +4 more
doaj   +1 more source

Presence of High‐Titer Neutralizing Antibodies against Enterovirus 71 in Intravenous Immunoglobulin Manufactured from Chinese Donors [PDF]

, 2009
Ruiyuan Cao, Jianfeng Han, Yong‐Qiang Deng, Man Yu, E-De Qin, Cheng‐Feng Qin   +5 more
openalex   +1 more source

Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays

Nature Protocols, 2021
K. Bewley, N. Coombes, L. Gagnon, Lorna McInroy, Natalie Baker, Imam Shaik, J. St-Jean, Natalie St-Amant, K. Buttigieg, H. Humphries, K. Godwin, Emily Brunt, Lauren Allen, Stephanie Leung, Phillip J. Brown, E. Penn, Kelly M. Thomas, Gregory Kulnis, B. Hallis, M. Carroll, S. Funnell, S. Charlton   +21 more
semanticscholar   +1 more source

From RNA to DNA: How Cargo Identity Reprograms Lipid Nanoparticle Architecture and Function

Advanced Healthcare Materials, EarlyView.
The evolution of lipid nanoparticles (LNPs) spans from RNA‐LNPs, used in mRNA vaccines, to DNA‐LNPs, ideal for gene therapies. Emerging bionano architectures, decorated with DNA and plasma proteins, pave the way for advanced DNA‐based therapies that are more stable, targeted, and customizable.
Erica Quagliarini, Daniela Pozzi, Giulio Caracciolo   +2 more
wiley   +1 more source

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

Nature Microbiology, 2020
J. Seow, C. Graham, B. Merrick, S. Acors, S. Pickering, K. Steel, O. Hemmings, Aoife M. O’Byrne, N. Kouphou, R. Galão, G. Betancor, H. Wilson, A. Signell, H. Winstone, C. Kerridge, I. Huettner, Jose M. Jimenez-Guardeño, M. Lista, Nigel J. Temperton, L. Snell, K. Bisnauthsing, A. Moore, A. Green, L. Martinez, B. Stokes, J. Honey, A. Izquierdo-Barras, G. Arbane, Amita Patel, M. Tan, L. O'Connell, Geraldine O'Hara, E. Macmahon, S. Douthwaite, G. Nebbia, R. Batra, R. Martinez-Nunez, M. Shankar-Hari, J. Edgeworth, S. Neil, M. Malim, K. Doores   +41 more
semanticscholar   +1 more source